retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr $bct.v #immunotherapy #biotech #investing
Tech Investing News reports on clean tech, emerging tech, med tech, fintech, blockchain, gaming, security and helps investors make better investment decisions.